N-叔丁氧羰基-L-金刚烷基甘氨酸 | 361441-97-6

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 甘氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-叔丁氧羰基-L-金刚烷基甘氨酸
• 英文名称: (2S)-2-(1-adamantyl)-2-(tert-butoxycarbonylamino)acetic acid
• 英文别名: (2S)-2-(Adamantan-1-yl)-2-((tert-butoxycarbonyl)amino)acetic acid；(2S)-2-(1-adamantyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid
• CAS: 361441-97-6
• 化学式: C₁₇H₂₇NO₄
• 分子量: 309.406
• InChiKey: LJUATQZYDYSZPV-CQCMJFKXSA-N

物化性质

• 熔点：
  >300 °C (decomp)(Solv: ethyl acetate (141-78-6); ligroine (8032-32-4))
• 沸点：
  460.3±28.0 °C(Predicted)
• 密度：
  1.193
• 溶解度：
  可溶于氯仿（少许）、DMSO（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2924199090
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-Boc-L-adamantylglycine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: N-Boc-L-adamantylglycine
CAS number: 361441-97-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C17H27NO4
Molecular weight: 309.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-叔丁氧羰基-L-金刚烷基甘氨酸 在 吡啶 、 盐酸 、 potassium permanganate 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 、 三氟乙酸酐 、 potassium hydroxide 作用下， 以 四氢呋喃 、 水 、 乙酸乙酯 、 异丙醇 、 乙腈 为溶剂， 反应 23.0h， 生成 (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
  参考文献：
  名称：

  DPP-IV抑制剂沙格列汀的所有八种立体异构体的合成和生物学评估

  摘要：

  已经合成了沙格列汀的所有八个立体异构体，并评估了它们对DPP-IV的抑制活性。明确证实沙格列汀的构型对有效抑制DPP-IV至关重要。进行了对接研究，以阐明沙格列汀立体异构体的构型与活性之间的关系。Tyr662和Tyr470被认为是DPP-IV与抑制剂相互作用的关键残基。这项工作为进一步设计针对DPP-IV的抑制剂提供了有价值的信息。

  DOI：

  10.1016/j.bmc.2013.12.061
• 作为产物：
  描述：

  1-金刚烷甲酸 在 palladium dihydroxide 盐酸 、 lithium aluminium tetrahydride 、 草酰氯 、 氢气 、 potassium carbonate 、 sodium hydrogensulfite 、 溶剂黄146 、 二甲基亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 正己烷 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 为溶剂， -78.0~80.0 ℃ 、344.74 kPa 条件下， 反应 76.5h， 生成 N-叔丁氧羰基-L-金刚烷基甘氨酸
  参考文献：
  名称：

  沙格列汀（BMS-477118）的发现和临床前概况：一种高效，长效，口服活性的二肽基肽酶IV抑制剂，用于治疗2型糖尿病。

  摘要：

  为了进一步阐明我们先前公开的一系列β-季氨基酸连接的1-cis-4,5-methanoprolinenitrile二肽基肽酶IV（DPP-IV）抑制剂的结构-活性关系（SAR），人们进行了研究α-环烷基取代的甘氨酸的β位。尽管全身暴露不良，但乙烯基取代的化合物在急性大鼠离体血浆DPP-IV抑制模型中显示出更长的作用持续时间。制备了氧化的推定代谢物，并在测量Zucker（fa / fa）大鼠葡萄糖清除率的功效模型中显示了其前体的效价和延长的作用时间。这种方法扩展到金刚烷基甘氨酸衍生的抑制剂导致发现了高效抑制剂，

  DOI：

  10.1021/jm050261p

文献信息

• [EN] DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)<br/>[FR] COMPOSÉS DITERPÉNOÏDES AGISSANT SUR LA PROTÉINE KINASE C (PKC)
  申请人：K GEN INC

  公开号：WO2021062030A1

  公开（公告）日：2021-04-01

  This present disclosure relates to protein kinase C (PKC) modulating compounds, methods of treating a subject with cancer using the compounds, and combination treatments with a second therapeutic agent.

  本公开涉及蛋白激酶C（PKC）调节化合物，使用这些化合物治疗癌症患者的方法，以及与第二治疗剂联合治疗的方法。
• Synthesis of Adamantylglycine Using a Diastereoselective Grignard-to-Nitrone Addition
  作者：Volker Jäger、Alevtina Baskakova、Wolfgang Frey

  DOI：10.1055/s-0030-1258235

  日期：2010.11

  tert-leucine, adamantylglycine has so far received little attention. Here, a new, practical synthesis of adamantylglycine is described. This is based on a highly diastereoselective addition of adamantyl Grignard reagent to 2,3-O-cyclohexylideneglyceraldehyde N-benzylnitrone, mediated by the Lewis acid diethylaluminum chloride. Adamantylglycine is obtained from the nitrone in 6 steps and 28% yield as

  与具有大取代基的氨基酸如叔亮氨酸相反，金刚烷基甘氨酸迄今为止很少受到关注。在此，描述了一种新的实用的金刚烷基甘氨酸合成方法。这是基于由路易斯酸二乙基氯化铝介导的将金刚烷基格利雅试剂高度非对映选择性地添加到2，3- O-环己基甘油醛N-苄基硝基。以6个步骤从硝酮获得金刚烷基甘氨酸，其为晶体盐酸盐的产率为28％，其中掺入0.5甲醇。 甘油醛-手性硝酮-格氏添加-亲电子甘氨酸当量-晶体结构
• COMPOUNDS AND METHOD OF USE
  申请人：Ferro Therapeutics, Inc.

  公开号：US20190263802A1

  公开（公告）日：2019-08-29

  This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.

  本公开涉及具有诱导铁死亡活性的化合物，一种使用这些化合物治疗癌症患者的方法，以及与第二种治疗药物的联合治疗。
• [EN] A PROCESS FOR INDUSTRIAL PREPARATION OF [(S)-N-TERT BUTOXYCARBONYL-3-HYDROXY]ADAMANTYLGLYCINE<br/>[FR] PROCÉDÉ DE PRÉPARATION INDUSTRIELLE DE LA [(S)-N-TERT BUTOXYCARBONYL-3-HYDROXY]ADAMANTYLGLYCINE
  申请人：LEE PHARMA LTD

  公开号：WO2014057495A1

  公开（公告）日：2014-04-17

  A commercially viable process for industrial preparation of [(S)-n-tert butoxycarbonyl-3-hydroxy]adamantylglycine which is a key intermediate for saxagliptin synthesis and is represented by compound of Formula-VI. The compound-VI obtained by the process of present invention has more than 99.5% HPLC purity, not more than 0.15 % of dihydroxy impurity, not more than 0.05% of isomer impurity and not more than 0.1% of any unknown impurity. Formula (VI).

  一种工业制备[(S)-n-叔丁氧羰基-3-羟基]金刚烷基甘氨酸的商业可行过程，该物质是撒格列普汀合成的关键中间体，代表化合物的结构式为VI。本发明的工艺获得的化合物VI具有超过99.5%的HPLC纯度，不超过0.15%的二羟基杂质，不超过0.05%的异构体杂质和不超过0.1%的任何未知杂质。结构式（VI）。
• Ten-membered rings as key interaction motifs in folding of desmuramyl di-, tri-, and tetrapeptides
  作者：Rosana Ribić、Ivan Kodrin、Ivana Biljan、Marija Paurević、Srđanka Tomić

  DOI：10.1007/s11224-018-1234-x

  日期：2019.6

  this paper, the synthesis and conformational analysis of desmuramyl peptides, derivatives lacking the N-acetylmuramyl moiety, is described. Systematic conformational analysis (bottom-up approach) of peptides in zwitterionic and non-zwitterionic forms of corresponding desmuramyl di-, tri-, and tetrapeptides was performed and results were compared with experimental data obtained by NMR study. Ten-membered

  多肽是聚合肽聚糖的片段，是细菌细胞壁的独特成分，可作为免疫刺激剂（佐剂）。肽聚糖的最小生物活性单元是 N-乙酰胞壁酰-L-丙氨酰-D-异谷氨酰胺。在本文中，描述了去壁酰肽（缺乏 N-乙酰胞壁酰部分的衍生物）的合成和构象分析。对相应去壁酰二肽、三肽和四肽的两性离子和非两性离子形式的肽进行系统构象分析（自下而上的方法），并将结果与​​通过 NMR 研究获得的实验数据进行比较。十元环（C10，